Cong Claire Xu - SVP, Clinical Development at NovaBridge Biosciences

Issuer-level insider activity

Role
SVP, Clinical Development
Issuer ticker
NBP on Nasdaq
Identity Names, identifiers, and filing context for this profile. 1 identity field
Entity type
Individual
Source evidence Original filing metadata and source links for verification. 1 source field
Source filing history
Open source filing history

Past-year transaction volume for Cong Claire Xu in NovaBridge Biosciences

Buys

Open market
Shares
Avg price
Total value

Sells

Open market
Shares
-7,979
Avg price
$2.23
Total value
-$17,758

Net

Past year
Shares
-7,979
Share %
-100%
Total value
-$17,758

Reported holdings for Cong Claire Xu in NovaBridge Biosciences

Form 4 holding SVP, Clinical Development

NovaBridge Biosciences

Security class
Ordinary Shares
Shares / value
298,101
Estimated value
$265,309
Report date
06 Jul 2026
Price
$0.8900
Ownership
Direct
Form 4 holding SVP, Clinical Development

NovaBridge Biosciences

Security class
Restricted Share Units
Shares / value
0
Estimated value
Report date
04 Jul 2026
Price
Ownership
Direct
Underlying class
Ordinary Shares
Underlying amount

Transaction history for Cong Claire Xu in NovaBridge Biosciences

Sym Class Transaction % SEC-reported value SEC-reported price Shares Shares after Date Ownership
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .